Associated Papers
Synchronous diagnosis of multicentric glioma with distinct isocitrate dehydrogenase molecular profiles: a case report.
Mohan AA et al.
Cns Oncology, 2026
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.
Spiekman IAC et al.
International Journal of Cancer, 2026
Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic Infiltrates.
Oskarsdottir AR et al.
The American Journal of Surgical Pathology, 2026
A Systematic Review of Erdheim-Chester Disease and IgG4-Related Disease: Building a Diagnostic Framework for the Rheumatologist.
Gurugubelli S et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases, 2026
Oncocytic salivary gland carcinomas.
Alsugair Z et al.
Histology and Histopathology, 2026
Diagnostic accuracy of next-generation sequencing (NGS) for identifying actionable mutations in advanced non-small cell lung cancer: Systematic Review and Meta-Analysis.
Téllez Castillo N et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026
Langerhans Cell Histiocytosis in Cardiofaciocutaneous Syndrome.
Keehan L et al.
American Journal of Medical Genetics. Part A, 2026
Dideoxy Sequencing Enhances Detection of KIT Mutations in Gastrointestinal Stromal Tumors Initially Evaluated by Next-Generation Sequencing Hotspot Panels.
Robinson L et al.
The Journal of Molecular Diagnostics : Jmd, 2026
Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.
Matrone A et al.
Jcem Case Reports, 2026
Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome-associated dMMR Colorectal Cancer.
Gkekas I et al.
Anticancer Research, 2026
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report.
Shibata A et al.
Cancer Reports (hoboken, N.j.), 2026
Genetic analysis of key players in PI3K signaling cascade of colorectal carcinoma.
Pervaiz H et al.
Scientific Reports, 2026
Mutant Isocitrate dehydrogenase 1 sensitizes intrahepatic cholangiocarcinoma cells to MDM2 inhibitors.
Liu CT et al.
Cancer Research Communications, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer.
Sahin IH et al.
Npj Precision Oncology, 2026
SEAP-GETNE consensus on prognostic and predictive molecular biomarkers in thyroid cancer.
Ruz-Caracuel I et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia, 2026
IsoPS-DIA: Dual Functionality of Absolute Targeted Quantification and Global Proteome Profiling.
Chan HJ et al.
Analytical Chemistry, 2026
miR-424(322)~503 impairs colon cancer progression driven by PTEN deficiency.
Vidal-Sabanés M et al.
Cell Death & Disease, 2026
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.
Schmidt ST et al.
Signal Transduction and Targeted Therapy, 2026
Ameloblastoma Displays Primary Cilia Maintenance and CEP164 Overexpression.
Miyazaki R et al.
Journal of Dental Research, 2026
Mutational status of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): molecular analysis should be performed for NIFTPs with nuclear score 3.
Sako A et al.
Journal of Pathology and Translational Medicine, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.
Ree AH et al.
British Journal of Cancer, 2026
Integrating germline and tumor sequencing to improve hereditary cancer diagnosis and care.
de Voer RM et al.
European Journal of Human Genetics : Ejhg, 2026
Gastrointestinal Stromal Tumors: Molecular Mechanisms of Drug Resistance and Advances in Therapeutic Strategies.
Jingnuo D et al.
Journal of Gastroenterology and Hepatology, 2026
Molecular features in gangliogliomas: a systematic review.
Pereira BJA et al.
Child's Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery, 2026
Unveiling a new SORBS2::BRAF fusion in papillary thyroid carcinoma: insights from molecular diagnostics.
Dai Y et al.
Virchows Archiv : an International Journal of Pathology, 2026
Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.
Chakroborty D et al.
Iscience, 2026
Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling.
Martini G et al.
Nature Reviews. Clinical Oncology, 2026
A multiplex, prime editing framework for identifying drug resistance variants at scale.
Abadie FMC et al.
Cell Genomics, 2026
Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolution.
Ashford P et al.
Genome Research, 2026
Rare RET Variants in a Patient With MEN2A and Multiple Follicular-Derived Thyroid Tumors: A Case Report and Review of the Literature.
Song Y et al.
International Journal of Surgical Pathology, 2026
Ancestry and somatic profile indicate acral melanoma origin and prognosis.
Basurto-Lozada P et al.
Nature, 2026
Integrated Molecular Profiling of Colorectal Cancer by Tumor Location: Evidence from a Real-World Cohort with Primary and Metastatic Samples.
Cozac-Szoke AR et al.
Cancers, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.
Ito K et al.
Nature Communications, 2026
A meta-analysis identifies driver genes and characterizes the molecular epidemiology of colorectal cancer.
Olafsson S et al.
Scientific Reports, 2026
Molecular pathogenesis and therapeutic advances in RET fusion-positive papillary thyroid carcinoma.
Wei Y et al.
Pathology, Research and Practice, 2026
Outside canonical BRAF p.V600E Box: 7 novel BRAF gene fusions in BRAF p.V600E WT papillary thyroid carcinoma.
McGrath N et al.
Virchows Archiv : an International Journal of Pathology, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in Mice.
Tomassoni-Ardori F et al.
Cancer Research Communications, 2026
Emerging role of DNA polymerase epsilon non-exonuclease domain mutations in colorectal cancer: From sequence variants to clinical implications.
Xu JJ et al.
World Journal of Gastroenterology, 2026
Malignant struma ovarii: Advances in molecular pathogenesis, classification, diagnosis and treatment.
Lin W et al.
Histopathology, 2026
Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.
Suzuki S et al.
Pharmaceuticals (basel, Switzerland), 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.
Slørdahl KS et al.
Acta Oncologica (stockholm, Sweden), 2026
Highly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay.
Bai H et al.
Scientific Reports, 2026
Tracing the molecular route to progression in miRNA-biogenesis-defective thyroid lesions.
Chong AS et al.
Jci Insight, 2026
Influence of Chronic Lymphocytic Thyroiditis and BRAF V600E Mutation on Clinicopathological Features in Papillary Thyroid Carcinoma With Different Tumor Size.
Yang YX et al.
Annali Italiani Di Chirurgia, 2026
Genomic Profile of Non-Small Cell Lung Cancer in a Spanish Cohort: A 2-Year Descriptive Study Using Next-Generation Sequencing.
Carnero-Gregorio M et al.
Genes, 2026
From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review.
De Carli R et al.
Cancers, 2026
The molecular profile of ovarian struma ovarii.
Calejero I et al.
Human Pathology, 2026
Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas.
Gutmans J et al.
International Journal of Molecular Sciences, 2026